June 02, 2016
Strongbridge Biopharma plc Announces Presentation at Jefferies 2016 Healthcare Conference
Media
June 02, 2016
Publication of the LOCATION clinical study results in the renowned scientific journal of the European Atherosclerosis Society (EAS)
June 02, 2016
Targovax receives approval in Australia to conduct a clinical trial withTG02 – an immunotheraphy treatment targeting RAS mutations
June 01, 2016
BONESUPPORT™ Announces Nature Publication Of Pre-Clinical Study Highlighting CERAMENT™’s Attractive Bone Remodeling Properties and as a Local Drug Delivery Platform for Bone Disease
May 31, 2016
Strongbridge Biopharma plc Announces Presentation of COR-003 and COR-005 Data at the European Congress of Endocrinology
May 31, 2016
NORDIC NANOVECTOR CAPITAL MARKETS DAY 2016 TO HIGHLIGHT STRONG PROGRESS TOWARDS VISION OF BECOMING A SIGNIFICANT PLAYER IN HAEMATOLOGICAL CANCERS
May 31, 2016
Targovax to present at forthcoming conferences
May 30, 2016
Wilson Therapeutics presents encouraging clinical data on Decuprate® at the Congress of the European Academy of Neurology
May 25, 2016
GenSight Biologics announces the registration of its document de base in relation to its planned IPO on Euronext’s regulated market in Paris
May 23, 2016
NORDIC NANOVECTOR TO HOST CAPITAL MARKETS DAY IN OSLO ON 31 MAY 2016